Seminars in Ultrasound, CT and MRI
Volume 28, Issue 4 , Pages 249-257 , August 2007

Advances in Transrectal Ultrasound Imaging of the Prostate

  • Robert A. Linden, MD
    • ,
  • Ethan J. Halpern, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Ethan J. Halpern, Departments of Urology and Radiology, Jefferson Prostate Diagnostic Center and Kimmel Cancer Center, Thomas Jefferson University, 132 South 10th Street, Philadelphia, PA 19107.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130
  2. Wantanabe H, Kato H, Kato T, et al. Diagnostic application of the ultrasonotomography for the prostate. Jpn J Urol. 1968;59:273–279
  3. McNeal JE. Origin and development of carcinoma in the prostate. Cancer. 1969;23:24–33
  4. Byar DP, Mostofi FK. Carcinoma of the prostate: evaluation of certain pathologic features in 208 radical prostatectomies. Cancer. 1972;30:5–13
  5. McNeal JE, Redwine EA, Freiha FS, et al. Zonal distribution of prostatic adenocarcinoma (Correlation with histologic pattern and direction of spread). Am J Surg Pathol. 1988;12:897–906
  6. McNeal JE. The zonal anatomy of the prostate. Prostate. 1981;2:35–49
  7. Lee F, Bronson JP, Lerner RM, et al. Sonoelasticity imaging: results in in vitro tissue specimens. Radiology. 1991;181:237–239
  8. Krouskop TA, Wheeler TM, Kallel F, et al. Elastic moduli of breast and prostate tissues under compression. Ultrason Imaging. 1998;20:260–274
  9. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol. 1993;24:220–226
  10. Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143:401–409
  11. Wantanabe H, Igari D, Tanahashi Y, et al. Measurements of size and weight of prostate by means of transrectal ultrasonotomography. Tohoku J Exp Med. 1974;114:277–285
  12. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol. 1991;145:984–987
  13. Rifkin MD, Dahnert W, Kurtz AB. State of the art: endorectal sonography of the prostate gland. AJR Am J Roentgenol. 1990;154:691–700
  14. Dahnert WF, Hamper UM, Eggleston JC, et al. Prostatic evaluation by transrectal sonography with histopathologic correlation: echogenic appearance of early carcinoma. Radiology. 1986;158:97–102
  15. Shinohara K, Wheeler TM, Scardino PT. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol. 1989;142:76–82
  16. Halpern EJ, Strup SE. Using gray scale, color and power Doppler sonography to detect prostate cancer. AJR Am J Roentgenol. 2000;174:623–627
  17. Onur R, Littrup PJ, Pontes JE, et al. Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J Urol. 2004;172:512–514
  18. Terris MK, Macy M, Freiha FS. Transrectal ultrasound appearance of prostatic granulomas secondary to bacillus calmette-guerin instillation. J Urol. 1997;158:126–127
  19. Purohit RS, Shinohara K, Meng MV, et al. Imaging clinically localized prostate cancer. Urol Clin North Am. 2003;30:279–293
  20. Varghese SL, Grossfeld GD. The prostatic gland: malignancies other than adenocarcinomas. Radiol Clin North Am. 2000;38:179–202
  21. Oyen RH, Van de Vooorde WM, Van Poppel HP, et al. Benign hyperplastic nodules that originate in the peripheral zone of the prostate gland. Radiology. 1993;189:707–711
  22. Brawer MK. Quantitative microvessel density (A staging and prognostic marker for human prostate carcinoma). Cancer. 1996;78:345–349
  23. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology. 1993;186:509–513
  24. Kelly IMG, Lees WR, Rickards D. Prostate cancer and the role of color Doppler US. Radiology. 1993;189:153–156
  25. Newman JS, Bree RL, Rubin JM. Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology. 1995;195:86–90
  26. Shigeno K, Igawa H, Shirna H, et al. The role of colour Doppler ultrasonography in detecting prostate cancer. BJU Int. 2000;86:229–233
  27. Lavoipierre AM, Snow RM, Frydenberg M, et al. Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR Am J Roentgenol. 1998;171:205–210
  28. Corund F, Hamida K, Flam T, et al. Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol. 2000;175:1161–1168
  29. Ismail M, Peterson RO, Alexander AA, et al. Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology. 1997;50:906–912
  30. Halpern EJ, Frauscher F, Strup SE, et al. Prostate: high-frequency Doppler US imaging for cancer detection. Radiology. 2002;225:71–77
  31. Cornud F, Belin X, Piron D, et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology. 1997;49:709–715
  32. Patel U, Rickards D. The diagnostic value of colour Doppler flow in the peripheral zone of the prostate, with histologic correlation. BJU Int. 1994;74:590–595
  33. Keener TS, Winter TC, Berger R, et al. Prostate vascular flow: the effect of ejaculation as revealed on transrectal power Doppler sonography. AJR Am J Roentgenol. 2000;175:1169–1172
  34. Halpern EJ, Frauscher F, Forsberg F, et al. High frequency Doppler US of the prostate: effect of patient position. Radiology. 2002;222:634–690
  35. Cho JY, Kim SH, Lee SE. Diffuse prostatic lesions: role of color Doppler and power Doppler ultrasonography. J Ultrasound Med. 1998;17:283–287
  36. Okihara K, Kojima M, Naya Y, et al. Ultrasonic power Doppler imaging for prostatic cancer: a preliminary report. Tohoku J Exp Med. 1997;182:277–281
  37. Kay PA, Robb RA, Bostwick DG. Prostate cancer microvessels: a novel method for three-dimensional reconstruction and analysis. Prostate. 1998;37:270–277
  38. Fregene TA, Khanuja PS, Noto AC, et al. Tumor-associated angiogenesis in prostate cancer. Anticancer Res. 1993;13:2377–2382
  39. Brawer MK, Deering RE, Brown M, et al. Predictors of pathologic stage in prostate carcinoma, the role of neovascularity. Cancer. 1994;73:678–687
  40. Bostwick DG, Wheeler TM, Blute M, et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology. 1996;48:47–57
  41. Lissbrant IF, Stattin P, Damber JE, et al. Vascular density is a predictor of cancer-specific survival in prostate carcinoma. Prostate. 1997;33:38–45
  42. Borre M, Offerson BV, Nerstrom B, et al. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer. 1998;78:940–944
  43. Frauscher F, Klauser A, Halpern EJ. Contrast-enhanced transrectal ultrasound of the prostate: clinical utility and future applications for detection of prostate cancer. Electromedica. 2000;68:29–34
  44. Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents: a review. Ultrasound Med Biol. 1994;20:319–333
  45. Goldberg BB. Ultrasound contrast agents. London: Dunitz; 1997;
  46. Forsberg F, Goldberg BB, Liu JB, et al. On the feasibility of real-time, in vivo harmonic imaging with proteinaceous microspheres. Ultrasound Med. 1996;15:853–860
  47. Sedelaar JP, van Leenders GJ, Hulsbergen-van de Kaa CA, et al. Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol. 2001;40:285–293
  48. Strohmeyer D, Frauscher F, Klauser A, et al. Contrast-enhanced transrectal color Doppler ultasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. Anticancer Res. 2001;21:2907–2913
  49. Bogers HA, Sedelaar JP, Beerlage HP, et al. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology. 1999;54:97–104
  50. Roy C, Buy X, Lang H, et al. Contrast enhanced color Doppler endorectal sonograph of the prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol. 2003;170:69–72
  51. Frauscher F, Klauser A, Halpern EJ, et al. Detection of prostate cancer with a microbubble contrast agent. Lancet. 2001;357:1849–1850
  52. Frauscher F, Klauser A, Volgger H, et al. Comparison of contrast-enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on prostate cancer detection. J Urol. 2002;167:1648–1652
  53. de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres (Part one: simulations). Ultrasonics. 1994;32:447–453
  54. de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres (Part two: measurements). Ultrasonics. 1994;32:455–459
  55. Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Circulation. 1995;92:2391–2395
  56. Colon PJ, Richards DR, Moreno CA, et al. Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with FS069 during fundamental and second harmonic imaging. J Am Soc Echocardiogr. 1997;10:602–607
  57. Broillet A, Puginier J, Ventrone R, et al. Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent. Invest Radiol. 1998;33:209–215
  58. Halpern EJ, Verkh L, Forsberg F, et al. Initial experience with contrast-enhanced sonography of the prostate. AJR Am J Roentgenol. 2000;174:1757–1780
  59. Halpern EJ, Rosenberg M, Gomella LG. Prostate cancer: contrast-enhanced US for detection. Radiology. 2001;219:219–225
  60. Halpern EJ, McCue PA, Aksnes AK, et al. Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients. Radiology. 2002;222:361–366
  61. Halpern EJ, Ramey JR, Strup SE, et al. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer. 2005;104:2373–2383
  62. Halpern EJ, Linden RA, Forsberg F, et al. In: Detection of prostate cancer with contrast-enhanced microflow imaging. Oak Brook, IL: RSNA Publications; 2006;p. 395;Proceeding of the 92nd Annual Meeting of the Radiological Society of North America, Chicago, IL. Dec
  63. Halpern EJ, Linden RA, Forsberg F, et al. Detection of prostate cancer with contrast-enhanced microflow imaging. Laurel, MD: AIUM; 2007;Proceeding of the Annual Meeting of the American Institute of Ultrasound in Medicine, NY. March
  64. Ives EP, Gomella LG, Halpern EJ. Effect of dutasteride therapy on Doppler evaluation of the prostate: preliminary results. Radiology. 2005;237:197–201
  65. Taylor LS, Porter BC, Rubens DJ, et al. Three-dimensional sonelastography: principles and practices. Phys Med Biol. 2000;45:1477–1494
  66. Ophir J, Cespedes I, Ponnekanti H, et al. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging. 1991;13:111–134
  67. Cochlin DL, Ganatra RH, Griffiths DF. Elastography in the detection of prostatic cancer. Clin Radiol. 2002;57:1014–1020
  68. Konig K, Scheipers U, Pesavento A, et al. Initial experiences with real-time elastography guided biopsies of the prostate. J Urol. 2005;174:115–117
  69. Chaussy C, Thuroff S. High-intensity focused ultrasound in prostate cancer: results after 3 years. Mol Urol. 2000;4:179–182
  70. Chaussy CG, Thuroff S. High-intensive focused ultrasound in localized prostate cancer. J Endourol. 2000;14:293–299
  71. Gelet A, Chapelon JY, Bouvier R, et al. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol. 2000;14:519–528
  72. Thuroff S, Chaussy C, Vallancien G, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European Multicentric Study. J Endourol. 2003;17:673–677
  73. Gelet A, Chapelon JY, Murat FJ, et al. Prostate cancer control with transrectal HIFU in 124 patients: 7-years’ actuarial results. Eur Urol Suppl. 2006;5:133;(abstr)
  74. Joel AB, Lynch J. HIFU: an emerging treatment for prostate cancer. Contemp Urol. 2001;13:48–56

PII: S0887-2171(07)00044-3

doi: 10.1053/j.sult.2007.05.002

Seminars in Ultrasound, CT and MRI
Volume 28, Issue 4 , Pages 249-257 , August 2007

Article Tools

* Image Usage & Resolution